Peter E. Wu

1.2k total citations
50 papers, 649 citations indexed

About

Peter E. Wu is a scholar working on Geriatrics and Gerontology, Emergency Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter E. Wu has authored 50 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Geriatrics and Gerontology, 10 papers in Emergency Medicine and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter E. Wu's work include Pharmaceutical Practices and Patient Outcomes (11 papers), Poisoning and overdose treatments (6 papers) and COVID-19 and Mental Health (4 papers). Peter E. Wu is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (11 papers), Poisoning and overdose treatments (6 papers) and COVID-19 and Mental Health (4 papers). Peter E. Wu collaborates with scholars based in Canada, United States and Australia. Peter E. Wu's co-authors include Wayne L. Gold, Rima Styra, David N. Juurlink, Reena Pattani, Irfan A. Dhalla, Alexander Kumachev, Emily G. McDonald, James Downar, Todd C. Lee and Robyn Tamblyn and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Peter E. Wu

43 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter E. Wu Canada 13 193 185 98 91 84 50 649
Asim Ahmed Elnour United Arab Emirates 16 154 0.8× 152 0.8× 275 2.8× 44 0.5× 117 1.4× 79 1.1k
Chia Siang Kow Malaysia 20 65 0.3× 104 0.6× 109 1.1× 31 0.3× 34 0.4× 104 1.4k
Melissa E. Badowski United States 19 161 0.8× 43 0.2× 138 1.4× 119 1.3× 148 1.8× 71 1.1k
Nancy L. Dawson United States 16 154 0.8× 47 0.3× 96 1.0× 89 1.0× 141 1.7× 43 696
Manik Chhabra India 15 156 0.8× 72 0.4× 108 1.1× 23 0.3× 32 0.4× 61 628
Nasir Wabe Australia 17 112 0.6× 59 0.3× 140 1.4× 37 0.4× 74 0.9× 83 974
Kevin C. Farmer United States 16 205 1.1× 62 0.3× 349 3.6× 63 0.7× 184 2.2× 33 1.5k
William N. Dowd United States 16 277 1.4× 151 0.8× 33 0.3× 39 0.4× 274 3.3× 39 1.0k
Ejaz Cheema United Kingdom 16 180 0.9× 81 0.4× 358 3.7× 29 0.3× 106 1.3× 56 932
Zahraa Jalal United Kingdom 18 230 1.2× 86 0.5× 220 2.2× 20 0.2× 63 0.8× 57 824

Countries citing papers authored by Peter E. Wu

Since Specialization
Citations

This map shows the geographic impact of Peter E. Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Wu more than expected).

Fields of papers citing papers by Peter E. Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter E. Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Wu. The network helps show where Peter E. Wu may publish in the future.

Co-authorship network of co-authors of Peter E. Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Peter E. Wu. A scholar is included among the top collaborators of Peter E. Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter E. Wu. Peter E. Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mafi, John N., et al.. (2025). Hospitalizations and Mortality Among Older Adults With and Without Restricted Access to Nirmatrelvir-Ritonavir. JAMA. 333(13). 1172–1172. 2 indexed citations
2.
Melloni, Giorgio, et al.. (2025). Risk stratification for postoperative hypoxemia among bariatric surgery patients. Minerva Anestesiologica. 91(5). 376–384. 1 indexed citations
3.
Huang, Allen, James Downar, Peter E. Wu, et al.. (2025). Prescribing Patterns and Impact of Sedatives in Hospitalized Older Adults: A Secondary Analysis of the MedSafer Study. Journal of the American Geriatrics Society. 73(6). 1753–1761.
4.
Wu, Peter E., et al.. (2024). Hypertensive Encephalopathy Triggered by Indomethacin Use. SHILAP Revista de lepidopterología. 12(11). e9604–e9604.
5.
Wu, Peter E., Todd C. Lee, & Emily G. McDonald. (2023). What Should I Know About Medication Deprescribing?. JAMA Internal Medicine. 183(8). 891–891. 3 indexed citations
6.
Wu, Peter E., et al.. (2022). Tecovirimat for monkeypox. Canadian Medical Association Journal. 194(46). E1573–E1573. 4 indexed citations
7.
Wu, Peter E., Lisa Burry, Christine Soong, et al.. (2022). Melatonin for Insomnia in Medical Inpatients: A Narrative Review. Journal of Clinical Medicine. 12(1). 256–256. 6 indexed citations
8.
Styra, Rima, Laura Hawryluck, Allison McGeer, et al.. (2022). Support for health care workers and psychological distress: thinking about now and beyond the COVID-19 pandemic. Health Promotion and Chronic Disease Prevention in Canada. 42(10). 421–430. 8 indexed citations
9.
Wu, Peter E., et al.. (2021). Prolonged ketosis and glycosuria secondary to SGLT2 inhibitor therapy. SHILAP Revista de lepidopterología. 9(11). e05057–e05057. 9 indexed citations
10.
Wu, Peter E., et al.. (2021). Benign serous cystadenoma presenting with cough and back pain. Canadian Medical Association Journal. 193(33). E1304–E1304. 1 indexed citations
11.
Austin, Emily, et al.. (2021). A 54-year-old woman with chronic lithium toxicity. Canadian Medical Association Journal. 193(34). E1345–E1348.
12.
Gunaratne, Keith, Wayne L. Gold, & Peter E. Wu. (2020). Disseminated gonococcal infection: the importance of testing all mucosal sites. Canadian Medical Association Journal. 192(24). E652–E652. 2 indexed citations
13.
Wu, Peter E., et al.. (2020). Adverse Drug Events in Older Adults: Review of Adjudication Methods in Deprescribing Studies. Journal of the American Geriatrics Society. 68(7). 1594–1602. 19 indexed citations
14.
Goulding, Anna, Peter E. Wu, & Wayne L. Gold. (2020). A care escalation framework to address lapses in donning and doffing of personal protective equipment during the COVID-19 pandemic. American Journal of Infection Control. 48(12). 1566–1567. 4 indexed citations
15.
Wu, Peter E., Rima Styra, & Wayne L. Gold. (2020). Mitigating the psychological effects of COVID-19 on health care workers. Canadian Medical Association Journal. 192(17). E459–E460. 182 indexed citations
16.
Wegier, Pete, Ellen H. Koo, Shahin Ansari, et al.. (2019). mHOMR: a feasibility study of an automated system for identifying inpatients having an elevated risk of 1-year mortality. BMJ Quality & Safety. 28(12). 971–979. 22 indexed citations
17.
McDonald, Emily G., Peter E. Wu, Babak Rashidi, et al.. (2019). The MedSafer Study: A Controlled Trial of an Electronic Decision Support Tool for Deprescribing in Acute Care. Journal of the American Geriatrics Society. 67(9). 1843–1850. 54 indexed citations
18.
Downar, James, Gayathri Embuldeniya, Shahin Ansari, et al.. (2018). Automated Prospective Clinical Surveillance for Inpatients at Elevated Risk of One-year Mortality Using a Modified Hospital One-Year Mortality Risk (mHOMR) Score. Journal of Pain and Symptom Management. 56(6). e67–e67. 1 indexed citations
19.
Sharma, Arjun, Vivian Lo, Lauren Lapointe‐Shaw, et al.. (2017). A time-motion study of residents and medical students performing patient discharges from general internal medicine wards: a disjointed, interrupted process. Internal and Emergency Medicine. 12(6). 789–798. 8 indexed citations
20.
Dunbar‐Yaffe, Richard, Wayne L. Gold, & Peter E. Wu. (2017). Junior Rounds: an educational initiative to improve role transitions for junior residents. BMC Research Notes. 10(1). 694–694. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Asim Ahmed Elnour Breakdown of academic impact, for papers by Chia Siang Kow Breakdown of academic impact, for papers by Melissa E. Badowski Breakdown of academic impact, for papers by Nancy L. Dawson Breakdown of academic impact, for papers by Manik Chhabra Breakdown of academic impact, for papers by Nasir Wabe Breakdown of academic impact, for papers by Kevin C. Farmer Breakdown of academic impact, for papers by William N. Dowd Breakdown of academic impact, for papers by Ejaz Cheema Breakdown of academic impact, for papers by Zahraa Jalal
Rankless by CCL
2026